Randomized crossover trial of 'Roll-over' technique of abdominal paracentesis versus standard technique in suspected malignant ascites

Expert Rev Gastroenterol Hepatol. 2023 Mar;17(3):295-300. doi: 10.1080/17474124.2023.2181785. Epub 2023 Feb 21.

Abstract

Background: The sensitivity of single abdominal paracentesis for diagnosis of peritoneal carcinomatosis (PC) varies from 40-70%. We hypothesized that rolling-over the patient before paracentesis might improve the cytological yield.

Research design and methods: This was a single center pilot study with a randomized cross-over design. We compared the cytological yield of fluid obtained by roll-over technique (ROG) with standard paracentesis (SPG) in suspected PC. In the ROG group, patients were rolled side-to-side thrice, and the paracentesis was done within 1 minute. Each patient served as their own control, and the outcome assessor (cytopathologist) was blinded. The primary objective was to compare the tumor cell positivity between SPG and ROG groups.

Results: Of 71 patients, 62 were analyzed. Of 53 patients with malignancy-related ascites, 39 had PC. Most of the tumor cells were adenocarcinoma (30, 94%) with one patient each having suspicious cytology and one having lymphoma. The sensitivity for diagnosis of PC was (31/39) 79.49% in SPG group and (32/39) 82.05% in ROG group (p = 1.00). The cellularity was similar between both the groups (good cellularity in 58% of SPG and 60% of ROG, p = 1.00).

Conclusions: Rollover paracentesis did not improve the cytological yield of abdominal paracentesis.

Trial registration: CTRI/2020/06/025887 and NCT04232384.

Keywords: Malignant ascites; laparoscopy; peritoneal neoplasm; peritoneal tuberculosis; tuberculous peritonitis.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Ascites* / diagnosis
  • Ascites* / etiology
  • Ascites* / therapy
  • Ascitic Fluid / pathology
  • Cross-Over Studies
  • Humans
  • Paracentesis / adverse effects
  • Paracentesis / methods
  • Peritoneal Neoplasms*
  • Pilot Projects

Associated data

  • ClinicalTrials.gov/NCT04232384